Evidence map›Paper›PMID 27581360›Full record

ArticleBlood2016

Perturbed hematopoiesis in mice lacking ATMIN.

Fernando Anjos-Afonso, Joanna I Loizou, Amy Bradburn, Nnennaya Kanu, Sukhveer Purewal, Clive Da Costa, Dominique Bonnet, Axel Behrens

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Fernando Anjos-AfonsoHaematopoietic Stem Cell Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Joanna I LoizouMammalian Genetics Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Amy BradburnHaematopoietic Stem Cell Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Nnennaya KanuMammalian Genetics Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Sukhveer PurewalFlow Cytometry Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom; and.
Clive Da CostaMammalian Genetics Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Dominique BonnetHaematopoietic Stem Cell Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
Axel BehrensMammalian Genetics Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, London, United Kingdom.
The Francis Crick Institute · GBAustrian Academy of Sciences · ATUniversity College London · GB

Funding

Cancer Research UK FC001039Cancer Research UK FC001045European Research Council 281661Medical Research Council FC001039Medical Research Council FC001045Wellcome Trust FC001039Wellcome Trust FC001045
6 · The paper itself

Abstract

The ataxia telangiectasia mutated (ATM)-interacting protein ATMIN mediates noncanonical ATM signaling in response to oxidative and replicative stress conditions. Like ATM, ATMIN can function as a tumor suppressor in the hematopoietic system: deletion of Atmin under the control of CD19-Cre results in B-cell lymphomas in aging mice. ATM signaling is essential for lymphopoiesis and hematopoietic stem cell (HSC) function; however, little is known about the role of ATMIN in hematopoiesis. We thus sought to investigate whether the absence of ATMIN would affect primitive hematopoietic cells in an ATM-dependent or -independent manner. Apart from its role in B-cell development, we show that ATMIN has an ATM-independent function in the common myeloid progenitors (CMPs) by deletion of Atmin in the entire hematopoietic system using Vav-Cre. Despite the lack of lymphoma formation, ATMIN-deficient mice developed chronic leukopenia as a result of high levels of apoptosis in B cells and CMPs and induced a compensatory mechanism in which HSCs displayed enhanced cycling. Consequently, ATMIN-deficient HSCs showed impaired regeneration ability with the induction of the DNA oxidative stress response, especially when aged. ATMIN, therefore, has multiple roles in different cell types, and its absence results in perturbed hematopoiesis, especially during stress conditions and aging.

Indexed as

AgingHematopoietic Stem CellsTranscription FactorsAnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsB-LymphocytesChronic DiseaseGene DeletionHematopoiesisLeukopeniaMiceMice, KnockoutOxidative StressAtaxia Telangiectasia Mutated ProteinsATMIN protein, mouseAtm protein, mouseTranscription Factors

Identifiers

PMID27581360
PMCPMC5147016
OpenAlexW2514309929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.